Poland· PL-100457678
Bimzelx
A bimekizumab product containing bimekizumabum, registered in Poland by UCB Pharma S.A.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Bimekizumab is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AC21 (bimekizumab), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Bimekizumab · ATC L04AC21
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bimekizumab costs, country by country.
Normalised to the WHO defined daily dose (5.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bimekizumab · price per daily dose (5.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$43.14
The record
At a glance
URPL (Poland)- Active substance
- Bimekizumabum
- Manufacturer
- UCB Pharma S.A.
- Country
- Poland (PL)
- ATC code
- L04AC21
- ATC class
- Bimekizumab
- Defined daily dose
- 5.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05413787220618
- gtin05413787222452
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bimekizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBIMZELXUCB Pharma SA, Brusel
- United KingdomBimzelx 160mg/1ml solution for injection pre-filled pensUCB Pharma Ltd
- IcelandBimzelxUCB Pharma S.A.*
- NorwayBimzelxUCB Pharma S.A. (2)
- SwedenBimzelx 160 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- SpainBIMZELX 160 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAUcb Pharma
- BelgiumBimzelx 160 mgUCB Pharma
- SwitzerlandBimzelx
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bimzelx
- Liechtenstein · Bimzelx
- Norway · Bimzelx
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec3a6537-61b7-4171-94f6-d7bb5d9a132b GET /v1/drugs/ec3a6537-61b7-4171-94f6-d7bb5d9a132b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań we wstrzykiwaczu",
"source": "urpl",
"strength": "160 mg",
"packaging": "05413787220618 ¦ Rpz ¦ EU/1/21/1575/006 ¦ 141878\n2 wstrzykiwacze 1 ml\n05413787222452 ¦ Rpz ¦ EU/1/21/1575/005 ¦ 141879\n1 wstrzykiwacz 1 ml\nRpz ¦ EU/1/21/1575/007 ¦ 141880\n3 wstrzykiwacze 1 ml\nRpz ¦ EU/1/21/1575/008 ¦ 141881\n4 wstrzykiwacze 1 ml",
"substance": "Bimekizumabum 160 mg/ml",
"common_name": "Bimekizumabum",
"pl_product_id": "100457678",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about bimekizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.